Share Price and Basic Stock Data
Last Updated: January 28, 2026, 3:32 pm
| PEG Ratio | -4.55 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Emkay Global Financial Services Ltd operates within the Finance & Investments industry and has reported a market capitalization of ₹691 Cr. The company’s share price stood at ₹267, reflecting its valuation in the market. Over the past few quarters, Emkay has shown fluctuating sales figures, with ₹70.54 Cr in sales for September 2023, rising to ₹75.20 Cr in December 2023. This upward trajectory continued with a reported ₹90.98 Cr for March 2024. However, the company faced a decline in sales during the preceding quarters, with ₹42.15 Cr in March 2023 and ₹46.65 Cr in June 2023. The trailing twelve months (TTM) sales are reported at ₹293 Cr, indicating potential growth as the company aims for ₹360 Cr by March 2025. This illustrates a strategic focus on enhancing revenue streams and adapting to market dynamics, positioning Emkay Global for future growth amidst a competitive landscape.
Profitability and Efficiency Metrics
Emkay Global’s profitability metrics reveal a mixed performance. The reported net profit for the latest quarter stood at ₹22 Cr, with a net profit margin of 16.93% for March 2025, which is an improvement from previous years. The company’s operating profit margin (OPM) was recorded at 1.96%, indicating challenges in maintaining profitability during certain quarters, particularly with negative margins in early 2023. Despite this, the return on equity (ROE) is robust at 20.9%, suggesting effective utilization of shareholder funds, while the return on capital employed (ROCE) stood at 20.4%. The interest coverage ratio (ICR) of 11.40x indicates a strong ability to meet interest obligations, which is significantly higher than industry averages, reflecting efficient operational management. However, the cash conversion cycle (CCC) of 95 days signals potential inefficiencies in working capital management that could impact liquidity.
Balance Sheet Strength and Financial Ratios
Emkay Global’s balance sheet reflects a solid financial foundation, with total assets reported at ₹1,542 Cr and total liabilities at ₹1,233 Cr as of March 2025. The company’s reserves have grown to ₹276 Cr, providing a buffer for future investments and operational needs. Borrowings stood at ₹81 Cr, which is relatively low, contributing to a total debt-to-equity ratio of 0.19, indicating prudent financial leverage. The book value per share increased to ₹119.51, highlighting the company’s growing net worth per share. Financial ratios such as the current ratio at 1.41 and quick ratio at 1.41 suggest adequate liquidity to cover short-term obligations. However, the earnings yield of 10% could be viewed as low compared to typical sector norms, indicating that while the company is profitable, investor returns may not be optimal compared to peers.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Emkay Global indicates a stable ownership structure, with promoters holding 71.68% of the shares, reflecting strong insider confidence. Foreign institutional investors (FIIs) have increased their stake to 0.88%, while domestic institutional investors (DIIs) hold a minimal 0.03%. The public shareholding has risen to 27.41%, suggesting a growing interest among retail investors. The number of shareholders stood at 12,349, a slight increase from previous quarters, indicating sustained investor interest. However, the gradual decline in promoter holding from 74.49% in December 2022 to the current level may raise concerns about long-term control. The limited presence of institutional investors might also indicate a need for improved investor relations to attract larger stakes from FIIs and DIIs.
Outlook, Risks, and Final Insight
Looking ahead, Emkay Global is poised for growth, driven by its strategic focus on increasing revenue and profitability. However, the company faces several risks, including potential volatility in quarterly sales and operational challenges that could impact margins. Additionally, the high cash conversion cycle may hinder liquidity, particularly in uncertain market conditions. The company’s ability to manage expenses effectively will be crucial in maintaining profitability. Strengths include a strong ROE and ICR, which provide a cushion against financial distress. As Emkay navigates these dynamics, it must also enhance its engagement with institutional investors to strengthen its capital base. The overall outlook remains cautiously optimistic, contingent on the company’s operational execution and market conditions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 11.5 Cr. | 39.2 | 57.0/36.4 | 45.9 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,188 Cr. | 278 | 455/269 | 13.6 | 111 | 0.36 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 28.8 Cr. | 0.41 | 1.23/0.38 | 3.99 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 3.75 Cr. | 7.58 | 11.6/7.58 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 17.0 Cr. | 33.1 | 69.9/33.1 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 7,105.67 Cr | 1,265.31 | 67.47 | 3,844.55 | 0.38% | 21.71% | 14.20% | 7.28 |
All Competitor Stocks of Emkay Global Financial Services Ltd
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 56.62 | 54.32 | 42.15 | 46.65 | 70.54 | 75.20 | 90.98 | 82.69 | 108.02 | 77.30 | 71.04 | 72.97 | 72.09 |
| Expenses | 46.98 | 47.91 | 53.99 | 52.21 | 62.98 | 64.70 | 78.10 | 67.61 | 78.93 | 67.87 | 70.93 | 67.14 | 70.68 |
| Operating Profit | 9.64 | 6.41 | -11.84 | -5.56 | 7.56 | 10.50 | 12.88 | 15.08 | 29.09 | 9.43 | 0.11 | 5.83 | 1.41 |
| OPM % | 17.03% | 11.80% | -28.09% | -11.92% | 10.72% | 13.96% | 14.16% | 18.24% | 26.93% | 12.20% | 0.15% | 7.99% | 1.96% |
| Other Income | 1.34 | 1.94 | 8.30 | 9.13 | 7.52 | 8.19 | 8.44 | 6.43 | 6.78 | 6.58 | 5.81 | 4.78 | 4.99 |
| Interest | 0.91 | 1.25 | 1.34 | 0.83 | 1.12 | 1.29 | 1.66 | 1.78 | 1.65 | 1.84 | 1.68 | 2.44 | 2.80 |
| Depreciation | 2.28 | 2.44 | 2.44 | 1.98 | 2.08 | 2.68 | 3.06 | 2.62 | 2.79 | 2.94 | 3.29 | 2.91 | 3.28 |
| Profit before tax | 7.79 | 4.66 | -7.32 | 0.76 | 11.88 | 14.72 | 16.60 | 17.11 | 31.43 | 11.23 | 0.95 | 5.26 | 0.32 |
| Tax % | 19.64% | -84.55% | -27.46% | 119.74% | 18.94% | 16.51% | 37.35% | 18.47% | 17.88% | 22.26% | -786.32% | 8.75% | 6.25% |
| Net Profit | 6.12 | 8.74 | -5.37 | 0.34 | 9.27 | 12.26 | 10.56 | 13.87 | 25.91 | 8.57 | 8.49 | 4.78 | 0.46 |
| EPS in Rs | 2.48 | 3.55 | -2.18 | 0.14 | 3.76 | 4.97 | 4.28 | 5.61 | 10.43 | 3.43 | 3.35 | 1.88 | 0.18 |
Last Updated: January 1, 2026, 9:04 pm
Below is a detailed analysis of the quarterly data for Emkay Global Financial Services Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 72.09 Cr.. The value appears to be declining and may need further review. It has decreased from 72.97 Cr. (Jun 2025) to 72.09 Cr., marking a decrease of 0.88 Cr..
- For Expenses, as of Sep 2025, the value is 70.68 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 67.14 Cr. (Jun 2025) to 70.68 Cr., marking an increase of 3.54 Cr..
- For Operating Profit, as of Sep 2025, the value is 1.41 Cr.. The value appears to be declining and may need further review. It has decreased from 5.83 Cr. (Jun 2025) to 1.41 Cr., marking a decrease of 4.42 Cr..
- For OPM %, as of Sep 2025, the value is 1.96%. The value appears to be declining and may need further review. It has decreased from 7.99% (Jun 2025) to 1.96%, marking a decrease of 6.03%.
- For Other Income, as of Sep 2025, the value is 4.99 Cr.. The value appears strong and on an upward trend. It has increased from 4.78 Cr. (Jun 2025) to 4.99 Cr., marking an increase of 0.21 Cr..
- For Interest, as of Sep 2025, the value is 2.80 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.44 Cr. (Jun 2025) to 2.80 Cr., marking an increase of 0.36 Cr..
- For Depreciation, as of Sep 2025, the value is 3.28 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.91 Cr. (Jun 2025) to 3.28 Cr., marking an increase of 0.37 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.32 Cr.. The value appears to be declining and may need further review. It has decreased from 5.26 Cr. (Jun 2025) to 0.32 Cr., marking a decrease of 4.94 Cr..
- For Tax %, as of Sep 2025, the value is 6.25%. The value appears to be improving (decreasing) as expected. It has decreased from 8.75% (Jun 2025) to 6.25%, marking a decrease of 2.50%.
- For Net Profit, as of Sep 2025, the value is 0.46 Cr.. The value appears to be declining and may need further review. It has decreased from 4.78 Cr. (Jun 2025) to 0.46 Cr., marking a decrease of 4.32 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.18. The value appears to be declining and may need further review. It has decreased from 1.88 (Jun 2025) to 0.18, marking a decrease of 1.70.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:24 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 82 | 117 | 105 | 109 | 156 | 147 | 135 | 160 | 272 | 215 | 314 | 360 | 293 |
| Expenses | 76 | 82 | 82 | 85 | 111 | 124 | 137 | 134 | 217 | 189 | 258 | 282 | 277 |
| Operating Profit | 6 | 34 | 24 | 24 | 45 | 23 | -3 | 26 | 55 | 25 | 56 | 79 | 17 |
| OPM % | 8% | 29% | 22% | 22% | 29% | 15% | -2% | 16% | 20% | 12% | 18% | 22% | 6% |
| Other Income | 1 | -36 | 0 | 0 | 0 | 3 | 0 | 2 | 1 | 1 | 2 | 1 | 22 |
| Interest | 5 | 5 | 4 | 3 | 4 | 7 | 7 | 3 | 3 | 4 | 5 | 7 | 9 |
| Depreciation | 4 | 4 | 4 | 4 | 5 | 7 | 8 | 8 | 8 | 9 | 10 | 12 | 12 |
| Profit before tax | -3 | -11 | 17 | 16 | 37 | 12 | -17 | 17 | 46 | 12 | 44 | 61 | 18 |
| Tax % | 40% | 49% | 28% | 26% | 22% | 31% | -29% | 32% | 24% | -12% | 27% | 6% | |
| Net Profit | -4 | -16 | 12 | 12 | 29 | 9 | -13 | 11 | 34 | 14 | 32 | 57 | 22 |
| EPS in Rs | -1.62 | -6.44 | 4.92 | 4.99 | 11.66 | 3.55 | -5.11 | 4.52 | 13.72 | 5.71 | 13.14 | 22.40 | 8.84 |
| Dividend Payout % | 0% | 0% | 20% | 20% | 17% | 28% | 0% | 22% | 9% | 18% | 11% | 18% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -300.00% | 175.00% | 0.00% | 141.67% | -68.97% | -244.44% | 184.62% | 209.09% | -58.82% | 128.57% | 78.12% |
| Change in YoY Net Profit Growth (%) | 0.00% | 475.00% | -175.00% | 141.67% | -210.63% | -175.48% | 429.06% | 24.48% | -267.91% | 187.39% | -50.45% |
Emkay Global Financial Services Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 22% |
| 3 Years: | 10% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 46% |
| 3 Years: | 19% |
| TTM: | 4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 31% |
| 3 Years: | 36% |
| 1 Year: | 19% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 14% |
| 3 Years: | 14% |
| Last Year: | 21% |
Last Updated: September 5, 2025, 3:30 am
Balance Sheet
Last Updated: December 4, 2025, 1:12 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24 | 24 | 24 | 24 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 26 |
| Reserves | 105 | 89 | 98 | 111 | 137 | 142 | 128 | 142 | 176 | 186 | 216 | 278 | 276 |
| Borrowings | 34 | 35 | 11 | 49 | 34 | 23 | 10 | 17 | 44 | 33 | 52 | 68 | 81 |
| Other Liabilities | 110 | 112 | 92 | 116 | 169 | 136 | 218 | 381 | 519 | 488 | 772 | 862 | 1,159 |
| Total Liabilities | 274 | 261 | 226 | 299 | 365 | 326 | 381 | 565 | 764 | 731 | 1,065 | 1,233 | 1,542 |
| Fixed Assets | 39 | 36 | 35 | 35 | 33 | 35 | 38 | 34 | 32 | 38 | 43 | 41 | 43 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
| Investments | 3 | 4 | 11 | 26 | 36 | 28 | 16 | 29 | 34 | 24 | 26 | 32 | 40 |
| Other Assets | 232 | 221 | 180 | 237 | 296 | 263 | 327 | 501 | 696 | 669 | 996 | 1,160 | 1,459 |
| Total Assets | 274 | 261 | 226 | 299 | 365 | 326 | 381 | 565 | 764 | 731 | 1,065 | 1,233 | 1,542 |
Below is a detailed analysis of the balance sheet data for Emkay Global Financial Services Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 25.00 Cr. (Mar 2025) to 26.00 Cr., marking an increase of 1.00 Cr..
- For Reserves, as of Sep 2025, the value is 276.00 Cr.. The value appears to be declining and may need further review. It has decreased from 278.00 Cr. (Mar 2025) to 276.00 Cr., marking a decrease of 2.00 Cr..
- For Borrowings, as of Sep 2025, the value is 81.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 68.00 Cr. (Mar 2025) to 81.00 Cr., marking an increase of 13.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,159.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 862.00 Cr. (Mar 2025) to 1,159.00 Cr., marking an increase of 297.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,542.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,233.00 Cr. (Mar 2025) to 1,542.00 Cr., marking an increase of 309.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 43.00 Cr.. The value appears strong and on an upward trend. It has increased from 41.00 Cr. (Mar 2025) to 43.00 Cr., marking an increase of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 32.00 Cr. (Mar 2025) to 40.00 Cr., marking an increase of 8.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,459.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,160.00 Cr. (Mar 2025) to 1,459.00 Cr., marking an increase of 299.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,542.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,233.00 Cr. (Mar 2025) to 1,542.00 Cr., marking an increase of 309.00 Cr..
Notably, the Reserves (276.00 Cr.) exceed the Borrowings (81.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -28.00 | -1.00 | 13.00 | -25.00 | 11.00 | 0.00 | -13.00 | 9.00 | 11.00 | -8.00 | 4.00 | 11.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 173 | 169 | 66 | 218 | 208 | 146 | 145 | 152 | 119 | 179 | 145 | 95 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 173 | 169 | 66 | 218 | 208 | 146 | 145 | 152 | 119 | 179 | 145 | 95 |
| Working Capital Days | -6 | -59 | -161 | -172 | -150 | -134 | -353 | -564 | -372 | -380 | -463 | -271 |
| ROCE % | 2% | 19% | 14% | 12% | 22% | 9% | -6% | 12% | 23% | 7% | 17% | 20% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 22.80 | 13.16 | 5.71 | 13.72 | 4.52 |
| Diluted EPS (Rs.) | 21.95 | 12.74 | 5.68 | 12.97 | 4.52 |
| Cash EPS (Rs.) | 27.02 | 17.00 | 9.39 | 17.22 | 7.90 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 119.51 | 97.54 | 85.38 | 81.42 | 67.59 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 119.51 | 97.54 | 85.38 | 81.42 | 67.59 |
| Revenue From Operations / Share (Rs.) | 132.52 | 114.39 | 82.39 | 110.07 | 66.00 |
| PBDIT / Share (Rs.) | 31.27 | 23.13 | 10.55 | 23.07 | 12.30 |
| PBIT / Share (Rs.) | 26.68 | 19.16 | 6.83 | 20.00 | 9.20 |
| PBT / Share (Rs.) | 23.94 | 17.18 | 5.09 | 18.72 | 7.05 |
| Net Profit / Share (Rs.) | 22.44 | 13.03 | 5.66 | 14.15 | 4.80 |
| NP After MI And SOA / Share (Rs.) | 22.40 | 13.14 | 5.71 | 13.72 | 4.52 |
| PBDIT Margin (%) | 23.59 | 20.22 | 12.81 | 20.96 | 18.63 |
| PBIT Margin (%) | 20.13 | 16.75 | 8.28 | 18.16 | 13.94 |
| PBT Margin (%) | 18.06 | 15.01 | 6.17 | 17.00 | 10.68 |
| Net Profit Margin (%) | 16.93 | 11.39 | 6.87 | 12.85 | 7.28 |
| NP After MI And SOA Margin (%) | 16.90 | 11.48 | 6.93 | 12.46 | 6.85 |
| Return on Networth / Equity (%) | 18.74 | 13.46 | 6.69 | 16.84 | 6.69 |
| Return on Capital Employeed (%) | 16.67 | 15.98 | 6.82 | 18.20 | 11.91 |
| Return On Assets (%) | 4.60 | 3.04 | 1.92 | 4.42 | 1.97 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.14 | 0.01 |
| Total Debt / Equity (X) | 0.19 | 0.17 | 0.12 | 0.19 | 0.07 |
| Asset Turnover Ratio (%) | 0.29 | 0.31 | 0.26 | 0.27 | 0.31 |
| Current Ratio (X) | 1.41 | 1.31 | 1.38 | 1.46 | 1.38 |
| Quick Ratio (X) | 1.41 | 1.31 | 1.38 | 1.46 | 1.38 |
| Dividend Payout Ratio (NP) (%) | 6.54 | 7.59 | 21.88 | 7.28 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 5.43 | 5.83 | 13.24 | 5.94 | 0.00 |
| Earning Retention Ratio (%) | 93.46 | 92.41 | 78.12 | 92.72 | 0.00 |
| Cash Earning Retention Ratio (%) | 94.57 | 94.17 | 86.76 | 94.06 | 0.00 |
| Interest Coverage Ratio (X) | 11.40 | 11.64 | 6.08 | 18.01 | 5.73 |
| Interest Coverage Ratio (Post Tax) (X) | 9.18 | 7.24 | 4.27 | 12.06 | 3.24 |
| Enterprise Value (Cr.) | 58.78 | -251.00 | -164.08 | -116.33 | -163.84 |
| EV / Net Operating Revenue (X) | 0.17 | -0.88 | -0.80 | -0.42 | -1.01 |
| EV / EBITDA (X) | 0.74 | -4.39 | -6.31 | -2.05 | -5.41 |
| MarketCap / Net Operating Revenue (X) | 1.60 | 1.02 | 0.78 | 0.94 | 0.98 |
| Retention Ratios (%) | 93.45 | 92.40 | 78.11 | 92.71 | 0.00 |
| Price / BV (X) | 1.78 | 1.20 | 0.75 | 1.28 | 0.96 |
| Price / Net Operating Revenue (X) | 1.60 | 1.02 | 0.78 | 0.94 | 0.98 |
| EarningsYield | 0.10 | 0.11 | 0.08 | 0.13 | 0.06 |
After reviewing the key financial ratios for Emkay Global Financial Services Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 22.80. This value is within the healthy range. It has increased from 13.16 (Mar 24) to 22.80, marking an increase of 9.64.
- For Diluted EPS (Rs.), as of Mar 25, the value is 21.95. This value is within the healthy range. It has increased from 12.74 (Mar 24) to 21.95, marking an increase of 9.21.
- For Cash EPS (Rs.), as of Mar 25, the value is 27.02. This value is within the healthy range. It has increased from 17.00 (Mar 24) to 27.02, marking an increase of 10.02.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 119.51. It has increased from 97.54 (Mar 24) to 119.51, marking an increase of 21.97.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 119.51. It has increased from 97.54 (Mar 24) to 119.51, marking an increase of 21.97.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 132.52. It has increased from 114.39 (Mar 24) to 132.52, marking an increase of 18.13.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 31.27. This value is within the healthy range. It has increased from 23.13 (Mar 24) to 31.27, marking an increase of 8.14.
- For PBIT / Share (Rs.), as of Mar 25, the value is 26.68. This value is within the healthy range. It has increased from 19.16 (Mar 24) to 26.68, marking an increase of 7.52.
- For PBT / Share (Rs.), as of Mar 25, the value is 23.94. This value is within the healthy range. It has increased from 17.18 (Mar 24) to 23.94, marking an increase of 6.76.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 22.44. This value is within the healthy range. It has increased from 13.03 (Mar 24) to 22.44, marking an increase of 9.41.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 22.40. This value is within the healthy range. It has increased from 13.14 (Mar 24) to 22.40, marking an increase of 9.26.
- For PBDIT Margin (%), as of Mar 25, the value is 23.59. This value is within the healthy range. It has increased from 20.22 (Mar 24) to 23.59, marking an increase of 3.37.
- For PBIT Margin (%), as of Mar 25, the value is 20.13. This value exceeds the healthy maximum of 20. It has increased from 16.75 (Mar 24) to 20.13, marking an increase of 3.38.
- For PBT Margin (%), as of Mar 25, the value is 18.06. This value is within the healthy range. It has increased from 15.01 (Mar 24) to 18.06, marking an increase of 3.05.
- For Net Profit Margin (%), as of Mar 25, the value is 16.93. This value exceeds the healthy maximum of 10. It has increased from 11.39 (Mar 24) to 16.93, marking an increase of 5.54.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 16.90. This value is within the healthy range. It has increased from 11.48 (Mar 24) to 16.90, marking an increase of 5.42.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.74. This value is within the healthy range. It has increased from 13.46 (Mar 24) to 18.74, marking an increase of 5.28.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.67. This value is within the healthy range. It has increased from 15.98 (Mar 24) to 16.67, marking an increase of 0.69.
- For Return On Assets (%), as of Mar 25, the value is 4.60. This value is below the healthy minimum of 5. It has increased from 3.04 (Mar 24) to 4.60, marking an increase of 1.56.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.19. This value is within the healthy range. It has increased from 0.17 (Mar 24) to 0.19, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.29. It has decreased from 0.31 (Mar 24) to 0.29, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.41. This value is below the healthy minimum of 1.5. It has increased from 1.31 (Mar 24) to 1.41, marking an increase of 0.10.
- For Quick Ratio (X), as of Mar 25, the value is 1.41. This value is within the healthy range. It has increased from 1.31 (Mar 24) to 1.41, marking an increase of 0.10.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 6.54. This value is below the healthy minimum of 20. It has decreased from 7.59 (Mar 24) to 6.54, marking a decrease of 1.05.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.43. This value is below the healthy minimum of 20. It has decreased from 5.83 (Mar 24) to 5.43, marking a decrease of 0.40.
- For Earning Retention Ratio (%), as of Mar 25, the value is 93.46. This value exceeds the healthy maximum of 70. It has increased from 92.41 (Mar 24) to 93.46, marking an increase of 1.05.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.57. This value exceeds the healthy maximum of 70. It has increased from 94.17 (Mar 24) to 94.57, marking an increase of 0.40.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 11.40. This value is within the healthy range. It has decreased from 11.64 (Mar 24) to 11.40, marking a decrease of 0.24.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.18. This value is within the healthy range. It has increased from 7.24 (Mar 24) to 9.18, marking an increase of 1.94.
- For Enterprise Value (Cr.), as of Mar 25, the value is 58.78. It has increased from -251.00 (Mar 24) to 58.78, marking an increase of 309.78.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 1. It has increased from -0.88 (Mar 24) to 0.17, marking an increase of 1.05.
- For EV / EBITDA (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 5. It has increased from -4.39 (Mar 24) to 0.74, marking an increase of 5.13.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has increased from 1.02 (Mar 24) to 1.60, marking an increase of 0.58.
- For Retention Ratios (%), as of Mar 25, the value is 93.45. This value exceeds the healthy maximum of 70. It has increased from 92.40 (Mar 24) to 93.45, marking an increase of 1.05.
- For Price / BV (X), as of Mar 25, the value is 1.78. This value is within the healthy range. It has increased from 1.20 (Mar 24) to 1.78, marking an increase of 0.58.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has increased from 1.02 (Mar 24) to 1.60, marking an increase of 0.58.
- For EarningsYield, as of Mar 25, the value is 0.10. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 24) to 0.10, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Emkay Global Financial Services Ltd:
- Net Profit Margin: 16.93%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.67% (Industry Average ROCE: 21.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.74% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 9.18
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.41
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 38.3 (Industry average Stock P/E: 67.47)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.19
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 16.93%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | The Ruby, 7th Floor, Mumbai Maharashtra 400028 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. S K Saboo | Chairman |
| Mr. Krishna Kumar Karwa | Managing Director |
| Mr. Prakash Kacholia | Managing Director |
| Mr. Raunak Karwa | Non Executive Director |
| Dr. Bharat Kumar Singh | Independent Director |
| Dr. Satish Ugrankar | Independent Director |
| Mr. A Dhananjaya | Independent Director |
| Mrs. Hutokshi Wadia | Independent Woman Director |
FAQ
What is the intrinsic value of Emkay Global Financial Services Ltd?
Emkay Global Financial Services Ltd's intrinsic value (as of 28 January 2026) is ₹684.06 which is 156.20% higher the current market price of ₹267.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹691 Cr. market cap, FY2025-2026 high/low of ₹410/162, reserves of ₹276 Cr, and liabilities of ₹1,542 Cr.
What is the Market Cap of Emkay Global Financial Services Ltd?
The Market Cap of Emkay Global Financial Services Ltd is 691 Cr..
What is the current Stock Price of Emkay Global Financial Services Ltd as on 28 January 2026?
The current stock price of Emkay Global Financial Services Ltd as on 28 January 2026 is ₹267.
What is the High / Low of Emkay Global Financial Services Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Emkay Global Financial Services Ltd stocks is ₹410/162.
What is the Stock P/E of Emkay Global Financial Services Ltd?
The Stock P/E of Emkay Global Financial Services Ltd is 38.3.
What is the Book Value of Emkay Global Financial Services Ltd?
The Book Value of Emkay Global Financial Services Ltd is 116.
What is the Dividend Yield of Emkay Global Financial Services Ltd?
The Dividend Yield of Emkay Global Financial Services Ltd is 0.55 %.
What is the ROCE of Emkay Global Financial Services Ltd?
The ROCE of Emkay Global Financial Services Ltd is 20.4 %.
What is the ROE of Emkay Global Financial Services Ltd?
The ROE of Emkay Global Financial Services Ltd is 20.9 %.
What is the Face Value of Emkay Global Financial Services Ltd?
The Face Value of Emkay Global Financial Services Ltd is 10.0.